Lantheus Holdings (LNTH) EBT (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly EBT came in at $156.4 million in Q1 2026, up 62.03% year-on-year from $96.5 million in Q1 2025, and up 103.55% on a QoQ basis from $76.8 million in Q4 2025.
Lantheus Holdings (LNTH) EBT (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of EBT data on file, last reported at $156.4 million in Q1 2026.
- On a quarterly basis, EBT rose 62.03% year-over-year to $156.4 million in Q1 2026; TTM through Mar 2026 was $380.1 million, a 616.07% increase from a year earlier, with the FY2025 full-year figure at $320.3 million, up 29609.18% from the prior year.
- EBT for Q1 2026 stood at $156.4 million, up from $76.8 million in the prior quarter.
- Over the last five years, EBT for LNTH reached as high as $176.1 million in Q3 2024 and fell as low as -$430.7 million in Q4 2024.
- Historically, EBT has averaged $53.8 million across 5 years, with a median of $84.4 million in 2024.
- On a YoY basis, EBT climbed as much as 1642.4% in 2024 and fell as far as 411.18% in 2024.
- Year by year, EBT stood at -$176.2 million in 2022, then jumped by 178.53% to $138.4 million in 2023, then sank by 411.18% to -$430.7 million in 2024, then soared by 117.84% to $76.8 million in 2025, then jumped by 103.55% to $156.4 million in 2026.
- Per Business Quant data, the three most recent EBT figures were $156.4 million in Q1 2026, $76.8 million in Q4 2025, and $42.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 156.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156.41 Mn |
| Dec 31, 2025 | 76.84 Mn |
| Sep 30, 2025 | 42.38 Mn |
| Jun 30, 2025 | 104.52 Mn |
| Mar 31, 2025 | 96.53 Mn |
| Dec 31, 2024 | -430.68 Mn |
| Sep 30, 2024 | 176.12 Mn |
| Jun 30, 2024 | 84.37 Mn |
| Mar 31, 2024 | 171.27 Mn |
| Dec 31, 2023 | 138.40 Mn |
| Sep 30, 2023 | 159.96 Mn |
| Jun 30, 2023 | 123.69 Mn |
| Mar 31, 2023 | -11.10 Mn |
| Dec 31, 2022 | -176.24 Mn |
| Sep 30, 2022 | 83.02 Mn |
| Jun 30, 2022 | 62.05 Mn |
| Mar 31, 2022 | 57.90 Mn |
| Dec 31, 2021 | -41.01 Mn |
| Sep 30, 2021 | -19.84 Mn |
| Jun 30, 2021 | -28.54 Mn |